$3.16 Billion is the total value of BRIDGER MANAGEMENT, LLC's 44 reported holdings in Q2 2015. The portfolio turnover from Q1 2015 to Q2 2015 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SPY | New | SPDR S&P 500 ETF TRcall | $1,440,950,000 | – | 7,000,000 | +100.0% | 45.57% | – |
| AGN | New | ALLERGAN PLC | $62,914,000 | – | 207,322 | +100.0% | 1.99% | – |
| BCC | New | BOISE CASCADE CO DEL | $61,647,000 | – | 1,680,672 | +100.0% | 1.95% | – |
| PODD | New | INSULET CORP | $55,934,000 | – | 1,805,181 | +100.0% | 1.77% | – |
| CI | New | CIGNA CORPORATION | $54,501,000 | – | 336,429 | +100.0% | 1.72% | – |
| EXAS | New | EXACT SCIENCES CORP | $45,825,000 | – | 1,540,841 | +100.0% | 1.45% | – |
| WCG | New | WELLCARE HEALTH PLANS INC | $34,709,000 | – | 409,156 | +100.0% | 1.10% | – |
| MGM | New | MGM RESORTS INTERNATIONAL | $33,336,000 | – | 1,826,654 | +100.0% | 1.05% | – |
| REGN | New | REGENERON PHARMACEUTICALS | $27,614,000 | – | 54,132 | +100.0% | 0.87% | – |
| LBRDA | New | LIBERTY BROADBAND CORP | $17,619,000 | – | 345,680 | +100.0% | 0.56% | – |
| DYAX | New | DYAX CORP | $13,864,000 | – | 523,157 | +100.0% | 0.44% | – |
| SGYPQ | New | SYNERGY PHARMACEUTICALS DEL | $7,031,000 | – | 847,094 | +100.0% | 0.22% | – |
| BKFS | New | BLACK KNIGHT FINL SVCS INCcl a | $6,659,000 | – | 215,700 | +100.0% | 0.21% | – |
| LXRX | New | LEXICON PHARMACEUTICALS INC | $2,089,000 | – | 259,458 | +100.0% | 0.07% | – |
| NVLS | New | NIVALIS THERAPEUTICS INC | $452,000 | – | 33,159 | +100.0% | 0.01% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2015-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VERISIGN INC | 40 | Q1 2023 | 5.2% |
| TEVA PHARMACEUTICAL INDS LTD | 40 | Q3 2023 | 7.3% |
| MORGAN STANLEY | 35 | Q3 2023 | 11.8% |
| ALNYLAM PHARMACEUTICALS INC | 34 | Q3 2021 | 4.9% |
| POST HLDGS INC | 33 | Q4 2022 | 6.1% |
| TG THERAPEUTICS INC | 33 | Q3 2021 | 3.8% |
| CHARTER COMMUNICATIONS INC N | 30 | Q3 2023 | 7.2% |
| ATARA BIOTHERAPEUTICS INC | 29 | Q4 2021 | 6.4% |
| GODADDY INC | 28 | Q3 2023 | 8.9% |
| CENTENE CORP DEL | 28 | Q3 2022 | 6.2% |
View BRIDGER MANAGEMENT, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Surrozen, Inc./DESold out | February 14, 2022 | 0 | 0.0% |
| Atara Biotherapeutics, Inc. | February 16, 2021 | 1,524,760 | 1.8% |
| Dicerna Pharmaceuticals Inc | February 14, 2020 | 1,981,633 | 2.9% |
| TG THERAPEUTICS, INC. | February 14, 2020 | 1,907,492 | 1.9% |
| CHIMERIX INCSold out | February 14, 2017 | 0 | 0.0% |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC.Sold out | February 14, 2017 | 0 | 0.0% |
| SeaSpine Holdings CorpSold out | February 14, 2017 | 0 | 0.0% |
| Trovagene, Inc.Sold out | February 14, 2017 | 0 | 0.0% |
| ARROWHEAD RESEARCH CORPSold out | February 16, 2016 | 0 | 0.0% |
| PENNYMAC FINANCIAL SERVICES, INC.Sold out | February 16, 2016 | 0 | 0.0% |
View BRIDGER MANAGEMENT, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 144 | 2024-06-18 |
| 13F-HR | 2024-05-15 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR | 2024-02-14 |
View BRIDGER MANAGEMENT, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.